UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A-1
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 12, 2012
|
AMERICAN BIO MEDICA CORPORATION
|
(Exact name of registrant as specified in its charter)
|
New York
|
|
0-28666
|
|
14-1702188
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification
Number)
|
|
122 Smith Road, Kinderhook, NY
|
12106
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: 518-758-8158
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 4.01 Changes in Registrant’s Certifying Accountant
On January 3, 2012, American Bio Medica Corporation (the “Company”) filed a Current Report on Form 8-K (the “Report”) disclosing changes in the Company's certifying accountant and disclosing that the Company had requested a letter from UHY, LLP (“UHY”) addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made by the Company in the report.
A copy of the letter provided by UHY is attached as an Exhibit to this Amendment to the Report filed on January 3, 2012.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibit is filed with this Report on Form 8-K/A-1:
|
|
99.1
|
Letter from UHY LLP received January 12, 2012 and dated January 11, 2012 addressed to the United States Securities & Exchange Commission
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AMERICAN BIO MEDICA CORPORATION (Registrant)
|
| |
|
|
|
Dated: January 13, 2012
|
By:
|
/s/ Melissa A. Waterhouse
|
| |
|
Melissa A. Waterhouse
|
| |
|
Vice President & Chief Compliance Officer
|
| |
|
Corporate Secretary
|